EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Coenzyme Q10 ameliorates anxiety and depression‑like behavior associated with chronic opioid use and increases GDNF expression in the hippocampus of morphine‑dependent rats

Mobina Gheibi, Somayeh Nazari, Fahimeh Mohseni, Pooria Salehi Sangani, Farzaneh Felehkari, Saba Niknamfar, Hamed Ghazvini, Seyedeh Masoumeh Seyedhosseini Tamijani, Hamid Kalalian-Moghaddam, Hamid Jomehpour, Raheleh Rafaiee

Acta Neurobiologiae Experimentalis · 2025

DOI: 10.55782/ane-2025-2581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurobiologiae Experimentalis, 2025. Verfasst von Mobina Gheibi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Allied Medical School, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Ubiquinone, Hippocampus, Glial Cell Line-Derived Neurotrophic Factor, Anxiety. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opioid dependence is strongly associated with moderate to severe depression and anxiety. The primary objective of this investigation was to determine whether coenzyme Q10 (CoQ10) has the capacity to increase the level of glial cell line‑derived neurotrophic factor (GDNF), with the aim of ameliorating anxiety‑ and depression‑like behaviors in morphine (MOP)‑dependent rats. In this study, 40 male Wistar rats were randomly divided into five experimental groups: Oil group, MOP+Oil group, MOP+Q10‑100 group, MOP+Q10‑200 group, and MOP+Q10‑400 group. Rats received escalating doses of MOP (25 to 100 mg/kg, s.c.) once daily. After 21 days of drug dependency, CoQ10 was administered orally at doses of 100, 200, and 400 mg/kg once daily for four weeks. Behavioral assessments were conducted using the open field test, elevated plus maze, and forced swim test. GDNF expression in the hippocampus was evaluated using immunohistochemistry. Four weeks of CoQ10 treatment significantly improved anxiety‑ and depression‑like behaviors induced by MOP administration. Furthermore, CoQ10 significantly increased GDNF expression in the hippocampus. Oral administration of CoQ10 at doses of 100, 200, and 400 mg/kg over four weeks significantly reduced depressive‑ and anxiety‑related behaviors associated with prolonged MOP exposure. These behavioral improvements were accompanied by increased hippocampal GDNF expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquinoneHippocampusGlial Cell Line-Derived Neurotrophic FactorAnxietyDepressionMorphine DependenceAnimalsMaleRatsRats, WistarMorphineBehavior, AnimalDisease Models, AnimalAnalgesics, Opioid

Substanzen

Ubiquinonecoenzyme Q10Glial Cell Line-Derived Neurotrophic FactorMorphineAnalgesics, OpioidGdnf protein, rat

Autor:innen und Institutionen

  • Student Research Committee, Allied Medical School, Mazandaran University of Medical Sciences, Sari, Iran.
  • Student Research Committee, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Department of Addiction Studies, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
  • Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Zitieren

APA

Gheibi, M., Nazari, S., Mohseni, F., Salehi Sangani, P., Felehkari, F., Niknamfar, S., Ghazvini, H., Seyedhosseini Tamijani, S. M., Kalalian-Moghaddam, H., Jomehpour, H., & Rafaiee, R. (2025). Coenzyme Q10 ameliorates anxiety and depression‑like behavior associated with chronic opioid use and increases GDNF expression in the hippocampus of morphine‑dependent rats. Acta Neurobiologiae Experimentalis. https://doi.org/10.55782/ane-2025-2581

Vancouver

Gheibi M, Nazari S, Mohseni F, Salehi Sangani P, Felehkari F, Niknamfar S, et al. Coenzyme Q10 ameliorates anxiety and depression‑like behavior associated with chronic opioid use and increases GDNF expression in the hippocampus of morphine‑dependent rats. Acta Neurobiologiae Experimentalis. 2025. doi:10.55782/ane-2025-2581

BibTeX
@article{Gheibi2025,
  author = {Gheibi, Mobina and Nazari, Somayeh and Mohseni, Fahimeh and Salehi Sangani, Pooria and Felehkari, Farzaneh and Niknamfar, Saba and Ghazvini, Hamed and Seyedhosseini Tamijani, Seyedeh Masoumeh and Kalalian-Moghaddam, Hamid and Jomehpour, Hamid and Rafaiee, Raheleh},
  title = {Coenzyme Q10 ameliorates anxiety and depression‑like behavior associated with chronic opioid use and increases GDNF expression in the hippocampus of morphine‑dependent rats},
  journal = {Acta Neurobiologiae Experimentalis},
  year = {2025},
  doi = {10.55782/ane-2025-2581}
}
Kostenlos starten →